BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20979731)

  • 21. Impact of angina prior to acute ST-elevation myocardial infarction on short-term outcomes after primary percutaneous coronary intervention: results from the Shanghai Registry of Acute Coronary Syndrome (SRACE).
    Zhang Q; Zhang RY; Zhu TQ; Hu J; Yang ZK; Ding FH; Du R; Zhu ZB; Shen WF
    Chin Med J (Engl); 2012 Mar; 125(6):977-82. PubMed ID: 22613517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trimetazidine in geriatric patients with stable angina pectoris: the tiger study.
    Kölbel F; Bada V
    Int J Clin Pract; 2003 Dec; 57(10):867-70. PubMed ID: 14712887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical study of trimetazidine for myocardial protection in acute myocardial infarction].
    Dong XD; Hu DY; Jia SQ; Wang L; Yan SB
    Zhonghua Nei Ke Za Zhi; 2007 Aug; 46(8):633-6. PubMed ID: 17967230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Trimetazidine in the treatment of stable angina pectoris TRIADA-(trimetazidine in stable angina twice daily)].
    Chaloupka V
    Vnitr Lek; 2006 Jun; 52(6):609-14. PubMed ID: 16871765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapeutic value of trimetazidine in patients with coronary heart disease and left ventricular dysfunction].
    Multicentral Collaborative Group on Trimetazidine (Phase IV)
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Sep; 33(9):793-5. PubMed ID: 16266453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Changes of circulating endothelial progenitor cells in patients with coronary heart diseases before and after percutaneous coronary intervention].
    Luo YS; Qian JY; Zhang L; Ma JY; Huang D; Fan B; Ge JB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Feb; 38(2):126-30. PubMed ID: 20398557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.
    Veselka J; Zemánek D; Hájek P; Malý M; Adlová R; Martinkovicová L; Tesar D
    Am J Cardiol; 2009 Sep; 104(5):630-3. PubMed ID: 19699335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of trimetazidine in patients with recurrent angina: a subgroup analysis of the TRIMPOL II study.
    Ruzyllo W; Szwed H; Sadowski Z; Elikowski W; Grzelak-Szafranska H; Orszulak W; Szymczak K; Winter M
    Curr Med Res Opin; 2004 Sep; 20(9):1447-54. PubMed ID: 15383193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clopidogrel loading dose (300 versus 600 mg) strategies for patients with stable angina pectoris subjected to percutaneous coronary intervention.
    Wolfram RM; Torguson RL; Hassani SE; Xue Z; Gevorkian N; Pichard AD; Satler LF; Kent KM; Waksman R
    Am J Cardiol; 2006 Apr; 97(7):984-9. PubMed ID: 16563901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy.
    Marazzi G; Gebara O; Vitale C; Caminiti G; Wajngarten M; Volterrani M; Ramires JA; Rosano G; Fini M
    Adv Ther; 2009 Apr; 26(4):455-61. PubMed ID: 19396409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.
    Belardinelli R; Lacalaprice F; Faccenda E; Volpe L
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):533-40. PubMed ID: 18797405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of trimetazidine on incidence of myocardial injury and contrast-induced nephropathy in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention.
    Shehata M
    Am J Cardiol; 2014 Aug; 114(3):389-94. PubMed ID: 24927970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trimetazidine for stable angina pectoris.
    Cross HR
    Expert Opin Pharmacother; 2001 May; 2(5):857-75. PubMed ID: 11336628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of trimetazidine with atenolol in patients with syndrome X: effects on diastolic function and exercise tolerance.
    Leonardo F; Fragasso G; Rossetti E; Dabrowski P; Pagnotta P; Rosano GM; Chierchia SL
    Cardiologia; 1999 Dec; 44(12):1065-9. PubMed ID: 10687257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitroglycerin infusion after percutaneous coronary intervention does not influence short- and long-term outcome--a prospective NAPI (Nitroglycerin Administration after Percutaneous Intervention) study.
    Foryś J; Peruga J; Plewka M; Lipiec P; Jasińska A; Krzemińska-Pakuła M; Kasprzak J
    Kardiol Pol; 2007 Jul; 65(7):789-803; discussion 804-5. PubMed ID: 17694461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of two-day atorvastatin pretreatment on long-term outcome of patients with stable angina pectoris undergoing elective percutaneous coronary intervention.
    Veselka J; Zemánek D; Hájek P; Malý M; Adlová R; Martinkovičová L; Tomašov P; Tesař D
    Am J Cardiol; 2011 May; 107(9):1295-9. PubMed ID: 21349484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of the antithrombotlic effect and safety between intravenous nadroparin and unfractionated heparin in patients undergoing percutaneous coronary intervention].
    Zhu JH; Qiu YG; Chen JZ; Zhang FR; Fu GS; Shen FR; Huang WJ; Wang JA; Zhao LL; Tao QM; Zheng LR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Apr; 33(4):335-9. PubMed ID: 15932664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of urapidil on heart function and ventricular systolic synchrony in acute myocardial infarction patients with no-reflow phenomenon after percutaneous coronary intervention].
    Chen JL; Fu XH; Jiang YF; Fan WZ; Gu XS; Liu JJ; Geng W
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Apr; 20(4):197-9. PubMed ID: 18419949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease.
    Vitale C; Wajngaten M; Sposato B; Gebara O; Rossini P; Fini M; Volterrani M; Rosano GM
    Eur Heart J; 2004 Oct; 25(20):1814-21. PubMed ID: 15474696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary intervention.
    Pelliccia F; Pasceri V; Marazzi G; Rosano G; Greco C; Gaudio C
    Am Heart J; 2012 Jun; 163(6):1019-23. PubMed ID: 22709755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.